Demetrius Moutsiakis, M.D., M.P.H. Preventive Medicine - Public Health & General Preventive Medicine Medicare: May Accept Medicare Assignments Practice Location: 400 Horseblock Rd, Farmingville, NY 11738 Phone: 631-698-1552 |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Chemical engineers at UC Santa Barbara expect that their new process to create molecular probes may eventually result in the development of new drugs to treat cancer and other illnesses.
Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.
Global health consultant Alanna Shaikh writes in this post on the Global Network for Neglected Tropical Diseases' "End the Neglect" blog about the elimination of river blindness, or onchoceriasis, from Colombia and progress made against the disease in Mexico and Guatemala.
› Verified 5 days ago